Potent new painkiller stokes alarm in US

March 8, 2014 by Kerry Sheridan

A potent new painkiller hit the US market this week, despite warnings from top experts that the drug may deliver a deadly setback in America's battle with opioid addiction.

Zohydro ER can contain 10 times the amount of hydrocodone as the most popular prescription painkiller, Vicodin, and is easily crushable so it could be snorted, bearing none of the recent safeguards added to pills like OxyContin (oxycodone).

In a nation where some 15,000 people die annually from prescription painkiller use, the drug's approval has raised alarm among doctors, lawmakers and relatives of those lost to overdose.

Two senators have launched an investigation into practices by the US Food and Drug Administration, amid allegations that pharmaceutical companies eager for a chunk of the $9 billion painkiller market may have paid to influence regulators' decisions.

"It's almost unheard of," said Andrew Kolodny, president of the group Physicians for Responsible Opioid Prescribing.

"For FDA to approve a drug that is going to make a serious problem worse, it is pretty shocking."

Zohydro was approved in October 2013, even though a panel of FDA-convened experts voted against 11-2. The FDA is not obligated to follow the advice of its advisory committees, but it typically does.

An FDA spokesman told AFP the decision was made "after careful consideration," and "the product's benefits outweigh its risks when used as intended."

Zohydro contains pure hydrocodone in a range of doses, including time-release options that are much stronger than competitor products.

It does not contain acetaminophen, which can cause liver damage and death in high doses and is included in most other prescription opioids.

The drugmaker, California-based Zogenix, said in a statement that the "acetaminophen-free formulation of extended release hydrocodone is an important therapeutic option for certain ."

A mother's story

Musician and financial adviser Steve Rummler was one of the 100 million people in the United States who suffer from .

He was prescribed narcotic painkillers in 2005 for a lingering back injury.

"The doctor kept increasing the amounts that he would give to Steve," his mother, Judy Rummler, told AFP.

By 2009, Steve's family learned he was seeking painkillers from multiple sources. He tried to learn other ways of coping. He tried rehab for addiction.

"He seemed great for a very short period of time, then he relapsed because of his pain," said Rummler.

When his last refills ran out, he scored some heroin, and overdosed on July 1, 2011, at the age of 43.

"He was a totally different person the last few years of his life," said his mother, who now chairs a coalition of activists called Fed Up.

The group has held rallies and met with lawmakers in an effort to curb the epidemic, which public health experts say is also fueling a rise in heroin and street drug use.

One hundred people in the United States die each day from drug overdose, according to the Centers for Disease Control and Prevention.

Regulators have introduced some tighter rules, and drugs like Zohydro fall under Schedule II, which means the pills can only be dispensed with a written prescription.

But plenty of people, including kids as young as 10, find ways to get opioids, said Janina Kean, president and CEO of High Watch Recovery Center in Connecticut.

"They are being overly prescribed. They end up in people's medicine cabinets," she said in an interview.

"We have a huge crisis in our country."

Pay to play?

The Washington Post and Milwaukee Journal Sentinel reported in October that hundreds of emails released in a public records request showed pharmaceutical companies paid tens of thousands of dollars to attend FDA advisory panel meetings.

The FDA denied any impropriety, but US lawmakers have launched a probe into whether the payments influenced regulators' decisions to approve drugs like Zohydro.

"If these allegations are true, there is a clear, illegal conflict of interest between the FDA and these that puts consumer safety at risk," said Louisiana Senator David Vitter in a letter to the FDA last week.

Senator Chuck Schumer of New York has urged the Department of Health and Human Services to override the FDA and remove Zohydro from the market until protections to prevent abuse are added.

But that seems unlikely. The drug is already available in select US pharmacies, a spokeswoman for Zogenix said.

Explore further: US approves more powerful, pure hydrocodone drug (Update)

Related Stories

US approves more powerful, pure hydrocodone drug (Update)

October 25, 2013
The U.S. Food and Drug Administration has approved a stronger, single-ingredient version hydrocodone, the widely-abused prescription painkiller.

US panel opposes pure hydrocodone painkiller

December 9, 2012
(AP)—U.S. government health experts overwhelmingly voted against a stronger version of hydrocodone on Friday, questioning the need for a new form of one of most widely abused prescription painkillers.

Zohydro will create new addicts, addiction medicine expert says

March 6, 2014
(Medical Xpress)—Few benefits and many risks will result from the marketing of Zohydro, the extended-release formulation of hydrocodone, according to Richard D. Blondell, MD, vice chair for addiction medicine at the University ...

US urges acetaminophen limits due to liver risks

January 15, 2014
US regulators said Wednesday they are urging doctors to cease prescribing drugs that contain more than 325 milligrams of acetaminophen per tablet due to concerns over liver damage.

FDA panel wants limits on hydrocodone painkillers

January 25, 2013
Federal health advisors want new restrictions on hydrocodone, the highly addictive ingredient found in Vicodin and other widely abused prescription painkillers.

FDA panel weighs tougher restrictions on some prescription painkillers

January 24, 2013
(HealthDay)—A U.S. Food and Drug Administration advisory panel will meet Thursday and Friday to discuss the fate of certain painkillers that contain an opioid known as hydrocodone.

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

marko
5 / 5 (1) Mar 09, 2014
The FDA prescription is dollars for drugs.

When democracy is up for sale it can no longer be called a democracy, but a $mockracy.
DrJLD
5 / 5 (1) Mar 10, 2014
I am tired of seeing every advance for my chronic pain patients be grouped into a war on opiate addiction. For patients who need use of these medications, addiction is not a problem as long as the drugs and the patients are managed properly.

It is those people who do not stop the medication when the pain subsides from more acute pain problems who are the best candidates for addiction. Of course, people who use these drugs for pleasure are the most likely to become addicted (almost guaranteed).

There is no conspiracy here; just an attempt to solve one problem while ruining the hopes of those for whom this is not a problem. To believe that doctors will willy-nilly prescribe this new medication for mild acute and chronic pain is to show little understanding of how doctors actually work. Many of the people using these medications have more than one doctor (the doctors involved do not know of the others' existence). Or, they are stolen and used or sold on the street.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.